Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;407(6):2489-2498.
doi: 10.1007/s00423-022-02555-z. Epub 2022 May 21.

Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study

Samuel Frey  1   2   3 , Thomas Goronflot  4 , Claire Blanchard  1   2   3 , Clarisse Kerleau  5 , Pierre-Antoine Gourraud  2   4 , Matthieu Wargny  4 , Cécile Caillard  1 , Maryvonne Hourmant  2   5   6 , Lucile Figueres  2   5   6 , Éric Mirallié  7   8 ; DIVAT Consortium
Collaborators, Affiliations

Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study

Samuel Frey et al. Langenbecks Arch Surg. 2022 Sep.

Abstract

Purpose: Parathyroidectomy to treat tertiary hyperparathyroidism (THPT) is now on a par with calcimimetic treatment. The effects of cinacalcet and parathyroidectomy on kidney transplant function remain controversial. The aim of this study was to evaluate kidney transplant function in THPT patients treated either by parathyroidectomy, cinacalcet, or not treated.

Methods: Between 2009 and 2019, 231 patients with functional grafts presenting THPT, defined either by calcaemia superior to 2.5 mmol/L with elevated PTH level or hypercalcaemia with non-adapted PTH level 1 year after kidney transplantation, were included. Hyperparathyroid patients treated by cinacalcet and parathyroidectomy were matched for age, sex, graft rank, and baseline eGFR with cinacalcet-only and untreated patients. Conditional logistic regression models were used to compare eGFR variations 1 year after parathyroidectomy between operated patients and matched controls. Five-year survivals were compared with the Mantel-Cox test.

Results: Eleven patients treated with parathyroidectomy and cinacalcet were matched with 16 patients treated by cinacalcet-only and 29 untreated patients. Demographic characteristics were comparable between groups. Estimated odds ratios for eGFR evolution in operated patients compared with cinacalcet-only and untreated patients were 0.92 [95%CI 0.83-1.02] and 0.99 [0.89-1.10] respectively, indicating no significant impairment of eGFR 1 year after surgery. Five-year allograft survival was not significantly impaired in operated patients.

Conclusions: Parathyroidectomy did not appear to substantially alter or improve graft function 1 year after surgery or 5-year allograft survival. It could be hypothesized that in addition to its known benefits, parathyroidectomy can be safely performed vis-à-vis graft function in tertiary hyperparathyroidism.

Keywords: Calcimimetics; Cinacalcet; Kidney transplantation; Parathyroid; Parathyroidectomy; Tertiary hyperparathyroidism.

PubMed Disclaimer

References

    1. Naveh-Many T, Volovelsky O (2020) Parathyroid cell proliferation in secondary hyperparathyroidism of chronic kidney disease. Int J Mol Sci 21(12):4332 - PMC
    1. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19(5):1281–1287 - PubMed
    1. Evenepoel P (2013) Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. Semin Nephrol 33(2):191–203 - PubMed
    1. Heaf J, Tvedegaard E, Kanstrup I-L, Fogh-Andersen N (2003) Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant 17(3):268–274 - PubMed
    1. Heaf J, Tvedegaard E, Kanstrup I-L, Fogh-Andersen N (2000) Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14(5):457–463 - PubMed

LinkOut - more resources